BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21466470)

  • 1. NK-1 receptor antagonists: a new paradigm in pharmacological therapy.
    Muñoz M; Coveñas R
    Curr Med Chem; 2011; 18(12):1820-31. PubMed ID: 21466470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new frontier in the treatment of cancer: NK-1 receptor antagonists.
    Muñoz M; Rosso M; Coveñas R
    Curr Med Chem; 2010; 17(6):504-16. PubMed ID: 20015033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK-1 receptor antagonists: a new generation of anticancer drugs.
    Munoz M; Covenas R
    Mini Rev Med Chem; 2012 Jun; 12(7):593-9. PubMed ID: 22512565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.
    Munoz M; Covenas R; Esteban F; Redondo M
    J Biosci; 2015 Jun; 40(2):441-63. PubMed ID: 25963269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NK-1 receptor: a new target in cancer therapy.
    Muñoz M; Rosso M; Coveñas R
    Curr Drug Targets; 2011 Jun; 12(6):909-21. PubMed ID: 21226668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of substance P and the NK-1 receptor in human pathology.
    Muñoz M; Coveñas R
    Amino Acids; 2014 Jul; 46(7):1727-50. PubMed ID: 24705689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of substance P and the NK-1 receptor in pancreatic cancer.
    Muñoz M; Coveñas R
    World J Gastroenterol; 2014 Mar; 20(9):2321-34. PubMed ID: 24605029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurokinin-1 receptor: a new promising target in the treatment of cancer.
    Muñoz M; Coveñas R
    Discov Med; 2010 Oct; 10(53):305-13. PubMed ID: 21034671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurokinin-1 receptor antagonists as antitumor drugs in gastrointestinal cancer: A new approach.
    Muñoz M; Coveñas R
    Saudi J Gastroenterol; 2016; 22(4):260-8. PubMed ID: 27488320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiproliferative action of [D-Arg(1), D-Phe(5), D-Trp(7,9), LEU(11)] substance P analogue antagonist against small-cell- and non-small-cell lung cancer cells could be due to the pharmacological profile of its tachykinin receptor antagonist.
    Munoz M; Recio S; Rosso M; Redondo M; Covenas R
    J Physiol Pharmacol; 2015 Jun; 66(3):421-6. PubMed ID: 26084224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioma and Neurokinin-1 Receptor Antagonists: A New Therapeutic Approach.
    Muñoz M; Coveñas R
    Anticancer Agents Med Chem; 2019; 19(1):92-100. PubMed ID: 29692265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2.
    Muñoz M; Rosso M; Aguilar FJ; González-Moles MA; Redondo M; Esteban F
    Invest New Drugs; 2008 Apr; 26(2):111-8. PubMed ID: 17906845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK-1 receptor antagonists as antitumor drugs: a survey of the literature from 2000 to 2011.
    Muñoz M; Martinez-Armesto J; Coveñas R
    Expert Opin Ther Pat; 2012 Jul; 22(7):735-46. PubMed ID: 22697287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple Negative Breast Cancer: How Neurokinin-1 Receptor Antagonists Could Be Used as a New Therapeutic Approach.
    Muñoz M; Rosso M; Coveñas R
    Mini Rev Med Chem; 2020; 20(5):408-417. PubMed ID: 31721701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer progression and substance P.
    Coveñas R; Muñoz M
    Histol Histopathol; 2014 Jul; 29(7):881-90. PubMed ID: 24535838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurokinin-1 Receptor Antagonists against Hepatoblastoma.
    Muñoz M; Rosso M; Coveñas R
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31466222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists.
    Muñoz M; González-Ortega A; Rosso M; Robles-Frias MJ; Carranza A; Salinas-Martín MV; Coveñas R
    Peptides; 2012 Dec; 38(2):318-25. PubMed ID: 23026680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.
    Herpfer I; Lieb K
    CNS Drugs; 2005; 19(4):275-93. PubMed ID: 15813642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of substance P and the NK-1 receptor in cancer progression.
    Muñoz M; Coveñas R
    Peptides; 2013 Oct; 48():1-9. PubMed ID: 23933301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of neurokinin-1 receptor antagonists.
    Muñoz M; Coveñas R
    Expert Opin Drug Saf; 2013 Sep; 12(5):673-85. PubMed ID: 23706125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.